PVIC Summer Series 2020
We started with a vision to talk about PV Innovation with our customers in person in Frankfurt & Copenhagen, the world changes but it doesn't mean that RxLogix PV Innovation does! Join us for our series of co-presented webinars starting July 1st. A personal big thank you to all of the speakers Christian Boschker, Astrid Schneider, Ph.D., Yvonne Nanciu, Lykke Bjerglund Graff, MD, Ph.D. & Shalin Patel for dedicating your time!
Christian Boschker, Merck
Director, Drug Safety, EU
Topic: PV Intake, the journey so far - Merck use case
Date: July 1st, 2020
Christian Boschker is a Director of Drug Safety at Merck and has more than 16 years of experience in Global Pharmacovigilance in various positions. He has a Master's degree in Medical Biology from Radboud University Nijmegen, the Netherlands and a Bachelor's degree in Clinical Chemistry from the University of Rijkshogeschool IJsselland Deventer. Currently, Christian is a Global Safety Regional Leader responsible for PV activities and implementation of PV intake at MSD in Middle and Eastern Europe. He supervises PV Country Leads and Regional Support personnel and ensures Quality and Compliance along with PV processes, policies and procedures are met.
Astrid Schneider, CSL
Director, Safety Sciences Reporting & Analytics
Topic: Launch of a new reporting tool in a growing global biotech company
Date: July 8th, 2020
Astrid Schneider is a Director of Safety Sciences - Reporting & Analytics at CSL Behring. She is responsible for managing global safety science expert teams like Global Aggregate Reporting & Safety Medical Writing, Medical Coding, Safety Data Analysis and Retrieval and Global Safety Literature Surveillance. She has a Ph.D. in Chemistry from Albert-Ludwigs-University in Freiburg, Germany. Astrid has more than 17 years of experience in various positions for Clinical Research (TAs: Neuroscience, Vaccines, Critical Care) as well as in PV RiskManagement/Safety Sciences (last seven years).
Yvonne Nanciu, Abbvie
Senior Manager, Pharmacovigilance & Medical Information
Topic: Signal detection and management- A clients experience of Sieve Analysis
Date: July 15th, 2020
Yvonne Nanciu comes from a multicultural background and is a medical doctor who specializes in Clinical Genetics and has a Master's degree in Pharmaceutical Medicine. She has a range of clinical and laboratory expertise and over 13 years of global clinical and local/global post-marketing pharmacovigilance experience. Yvonne has been a team-leader and manager for over 10 years with excellent communication skills in several languages.
Lykke Bjerglund, Leo Pharma
VP Global Safety
Topic: The future of PV-LEO PV 2025 strategy
Date: July 22nd, 2020
Lykke Bjerglund Graff is VP of Global Safety at LEO Pharma, Copenhagen. She has an MD and a Ph.D. degree from the University of Copenhagen and an MMPI (Managing Medical Product Innovation) diploma from the Scandinavian International Management Institute of Copenhagen. Lykke has nine years of clinical experience within various medical and surgical specialties and more than 20 years of experience within the pharmaceutical industry in clinical development and pharmacovigilance.
Shalin Patel, J&J
Senior Director, Global Head of Safety Evaluation & Reporting
Topic: To Change or Not to Change: 21st Century PV Reporting
Date: July 27th, 2020
Shalin Patel has more than 18 years of experience in PV and is currently the Senior Director of Global Head of Safety Evaluation and Reporting at the J&J Consumer, based in the UK. He is responsible for providing strategic management and defining the PV operational framework for Case Management, Aggregate Reporting and PV reporting from commercial programs. Shalin has held various other roles within PV both in Janssen and the J&J Consumer Companies, including two international assignments in China and India leading the Local Safety Office and providing Vendor Oversight, respectively.